BCAB
BioAtla, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Strong sell
-59/100
Last price
1.35
▲ 0.03 (2.27%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1.31
Prev close
1.32
Day high
1.40
Day low
1.22
Volume
5.48K
Market cap
$2.25M
P/E (TTM)
—
52W range
1.07 – 71.50
Day trading desk
Gap from prior close
-0.76%
Prior close 1.32
VWAP
1.31
+3.02% from price
Relative volume
0.09×
Quiet session
Session range
14.75%
1.22 – 1.40
Position in range
72%
Near session high
ATR (14D)
0.38
28.38% of price
Prior day high
1.32
PDH
Prior day low
1.23
PDL
Bid / ask spread
—
Quote not published
Session volume
5.38K
Avg 62.65K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.74%
-2.7%
1M
+2.27%
+1.1%
3M
-62.40%
-66.9%
6M
-71.03%
-89.2%
YTD
-95.25%
-109.5%
1Y
-96.11%
-112.5%
3Y
-98.41%
-180.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on BCAB open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
90.05K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Mar 11, 26 | SHORT JAY M Chief Executive Officer |
STOCK | 430.00K | $0 | Direct |
| Mar 10, 26 | VASQUEZ CHRISTIAN J Chief Financial Officer |
STOCK | 240.00K | $0 | Direct |
| Mar 10, 26 | SIEVERS ERIC L Officer |
STOCK | 240.00K | $0 | Direct |
| Jun 18, 25 | STEINMAN LAWRENCE Director |
STOCK | 23.50K | $0 | Direct |
| Jun 18, 25 | MORAN SUSAN Director |
STOCK | 23.50K | $0 | Direct |
| Jun 18, 25 | GRAY MARY ANN Director |
STOCK | 23.50K | $0 | Direct |
| Jun 18, 25 | MCBRINN SYLVIA Director |
STOCK | 23.50K | $0 | Direct |
| Jun 18, 25 | SMITH SCOTT ANDREW Director |
STOCK | 23.50K | $0 | Direct |
| Jun 18, 25 | WILLIAMS EDDIE Director |
STOCK | 23.50K | $0 | Direct |
| Mar 12, 25 | SHORT JAY M Chief Executive Officer |
STOCK | 431.00K | $0 | Direct |
| Mar 11, 25 | WALDRON RICHARD A Chief Financial Officer |
STOCK | 100.00K | $0 | Direct |
| Mar 11, 25 | VASQUEZ CHRISTIAN J Officer |
STOCK | 85.00K | $0 | Direct |
| Mar 11, 25 | SIEVERS ERIC L Officer |
STOCK | 175.00K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
GRAY MARY ANN |
Director | 77.40K | Stock Award(Grant) |
MCBRINN SYLVIA |
Director | 59.13K | Stock Award(Grant) |
MORAN SUSAN |
Director | 52.31K | Stock Award(Grant) |
SHORT JAY M |
Chief Executive Officer | 4.27M | Stock Award(Grant) |
SIEVERS ERIC L |
Officer | 598.71K | Stock Award(Grant) |
SMITH SCOTT ANDREW |
Director | 321.55K | Stock Award(Grant) |
STEINMAN LAWRENCE |
Director | 78.46K | Stock Award(Grant) |
VASQUEZ CHRISTIAN J |
Chief Financial Officer | 530.20K | Stock Award(Grant) |
WALDRON RICHARD A |
Chief Financial Officer | 333.26K | Stock Award(Grant) |
WILLIAMS EDDIE |
Director | 60.20K | Stock Award(Grant) |
Fundamentals
Market cap$2.25M
Enterprise value$6.57M
Revenue (TTM)$8.50M
Gross profit$-16.06M
EBITDA$-30.83M
Net income$-31.45M
EPS (TTM)$-25.23
Free cash flow$-11.86M
Total cash$1.54M
Total debt$5.86M
Book value / share$-21.79
Shares outstanding1.67M
Float1.39M
Short % of float0.00%
Dividend yield0.00%
Beta (5Y)0.63
Valuation & profitability ratios
Trailing P/E—
Forward P/E-1.01
PEG ratio—
Price / sales—
Price / book—
EV / revenue0.77
EV / EBITDA-0.21
Gross margin-188.92%
Operating margin3.49%
Profit margin0.00%
Return on equity—
Return on assets-105.86%
Debt / equity—
Current ratio0.20
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.00M | $11.00M | $0 | $0 | -81.8% |
| Operating revenue | $2.00M | $11.00M | $0 | $0 | -81.8% |
| Research & development | $43.57M | $63.09M | $103.73M | $79.35M | -30.9% |
| Selling, general & admin | $17.73M | $21.85M | $25.96M | $28.79M | -18.8% |
| Total operating expense | $61.30M | $84.94M | $129.69M | $108.14M | -27.8% |
| Operating income | -$59.30M | -$73.94M | -$129.69M | -$108.14M | +19.8% |
| Net interest income | $843.00K | $3.37M | $6.31M | $1.65M | -75.0% |
| Pre-tax income | -$59.61M | -$69.78M | -$123.46M | -$106.48M | +14.6% |
| Net income | -$59.61M | -$69.78M | -$123.46M | -$106.48M | +14.6% |
| Net income to common | -$59.61M | -$69.78M | -$123.46M | -$106.48M | +14.6% |
| Basic EPS | -50.50 | -60.05 | -129.00 | -49.79 | +15.9% |
| Diluted EPS | -50.50 | -60.05 | -129.00 | -49.79 | +15.9% |
| EBIT | -$59.30M | -$73.94M | -$129.69M | -$108.14M | +19.8% |
| EBITDA | -$58.93M | -$73.02M | -$128.47M | -$106.94M | +19.3% |
| Basic shares | 1.18M | 1.16M | 955.55K | 2.14M | +1.3% |
| Diluted shares | 1.18M | 1.16M | 955.55K | 2.14M | +1.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $7.12M | $49.05M | $111.47M | $215.51M | -85.5% |
| Cash & short-term investments | $7.12M | $49.05M | $111.47M | $215.51M | -85.5% |
| Total current assets | $8.01M | $51.23M | $116.41M | $220.43M | -84.4% |
| Property, plant & equipment | $5.65M | $1.19M | $3.10M | $5.15M | +375.0% |
| Total assets | $13.83M | $52.42M | $119.66M | $225.74M | -73.6% |
| Total current liabilities | $21.92M | $14.54M | $28.34M | $23.13M | +50.8% |
| Total debt | $6.20M | $836.00K | $2.46M | $3.98M | +641.6% |
| Total liabilities | $50.02M | $38.16M | $48.99M | $45.40M | +31.1% |
| Retained earnings | -$545.65M | -$486.04M | -$416.26M | -$292.80M | -12.3% |
| Shareholder equity | -$36.19M | $14.27M | $70.67M | $180.34M | -353.7% |
| Working capital | -$13.91M | $36.69M | $88.06M | $197.30M | -137.9% |
| Net tangible assets | -$36.19M | $14.27M | $70.67M | $180.34M | -353.7% |
| Shares issued | 1.27M | 1.16M | 961.55K | 2.14M | +9.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$59.61M | -$69.78M | -$123.46M | -$106.48M | — | +14.6% |
| Depreciation & amortisation | $373.00K | $925.00K | $1.22M | $1.20M | — | -59.7% |
| Stock-based compensation | $5.43M | $8.92M | $13.54M | $14.56M | — | -39.1% |
| Change in working capital | $4.28M | -$11.20M | $4.68M | $287.00K | — | +138.2% |
| Operating cash flow | -$48.20M | -$71.94M | -$104.02M | -$90.42M | — | +33.0% |
| Capital expenditure | — | — | -$98.00K | -$268.00K | -$924.00K | — |
| Investing cash flow | $0 | $0 | -$98.00K | -$265.00K | — | — |
| Financing cash flow | $6.28M | $9.51M | $77.00K | $61.21M | — | -34.0% |
| Free cash flow | -$48.20M | -$71.94M | -$104.11M | -$90.69M | — | +33.0% |
| End cash position | $7.12M | $49.05M | $111.47M | $215.51M | — | -85.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $6.50M | $0 | $2.00M | $0 | $0 | — |
| Operating revenue | $6.50M | $0 | $2.00M | $0 | $0 | — |
| Research & development | $3.34M | $4.58M | $8.00M | $9.54M | $13.68M | -27.1% |
| Selling, general & admin | $2.93M | $4.73M | $3.26M | $4.25M | $4.96M | -38.0% |
| Total operating expense | $6.27M | $9.31M | $11.26M | $13.79M | $18.65M | -32.6% |
| Operating income | $227.00K | -$9.31M | -$9.26M | -$13.79M | -$18.65M | +102.4% |
| Net interest income | $16.00K | $37.00K | $73.00K | $133.00K | $233.00K | -56.8% |
| Pre-tax income | $452.00K | -$6.34M | -$9.78M | -$15.78M | -$18.71M | +107.1% |
| Net income | $452.00K | -$6.34M | -$9.78M | -$15.78M | -$18.71M | +107.1% |
| Net income to common | $452.00K | -$6.34M | -$9.78M | -$15.78M | -$18.71M | +107.1% |
| Basic EPS | 0.27 | -4.22 | -8.00 | -13.50 | -16.00 | +106.4% |
| Diluted EPS | 0.27 | -4.22 | -8.00 | -13.50 | -16.00 | +106.4% |
| EBIT | $227.00K | -$9.31M | -$9.26M | -$13.79M | -$18.65M | +102.4% |
| EBITDA | $227.00K | -$9.19M | -$9.24M | -$13.73M | -$18.53M | +102.5% |
| Basic shares | 1.66M | 1.50M | 1.20M | 1.17M | 1.17M | +10.6% |
| Diluted shares | 1.66M | 1.50M | 1.20M | 1.17M | 1.17M | +10.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.54M | $1.96M | $7.12M | $8.32M | $18.21M | -21.3% |
| Cash & short-term investments | $1.54M | $1.96M | $7.12M | $8.32M | $18.21M | -21.3% |
| Accounts receivable | $2.00M | — | — | — | — | — |
| Total current assets | $4.26M | $3.09M | $8.01M | $9.67M | $20.61M | +37.7% |
| Property, plant & equipment | $5.08M | $5.31M | $5.65M | $6.08M | $6.35M | -4.2% |
| Total assets | $9.51M | $8.57M | $13.83M | $15.91M | $27.13M | +11.0% |
| Total current liabilities | $21.02M | $20.69M | $21.92M | $17.98M | $16.60M | +1.6% |
| Total debt | $5.86M | $6.09M | $6.20M | $6.18M | $6.04M | -3.8% |
| Total liabilities | $45.74M | $45.88M | $50.02M | $47.15M | $43.87M | -0.3% |
| Retained earnings | -$551.54M | -$551.99M | -$545.65M | -$535.86M | -$520.08M | +0.1% |
| Shareholder equity | -$36.24M | -$37.31M | -$36.19M | -$31.24M | -$16.75M | +2.9% |
| Working capital | -$16.76M | -$17.60M | -$13.91M | -$8.31M | $4.01M | +4.8% |
| Net tangible assets | -$36.24M | -$37.31M | -$36.19M | -$31.24M | -$16.75M | +2.9% |
| Shares issued | 1.66M | 1.66M | 1.27M | 1.18M | 1.17M | +0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $452.00K | -$6.34M | -$9.78M | -$15.78M | -$18.71M | — | +107.1% |
| Depreciation & amortisation | $0 | $120.00K | $19.00K | $56.00K | $115.00K | — | -100.0% |
| Stock-based compensation | $619.00K | $956.00K | $1.12M | $1.29M | $1.38M | — | -35.3% |
| Change in working capital | -$1.27M | $2.95M | -$54.00K | $2.43M | $2.80M | — | -143.1% |
| Operating cash flow | -$419.00K | -$5.27M | -$7.92M | -$9.88M | -$14.12M | — | +92.0% |
| Investing cash flow | — | — | — | — | — | $0 | — |
| Financing cash flow | $2.00K | $110.00K | $6.71M | -$6.00K | -$36.00K | — | -98.2% |
| Free cash flow | -$419.00K | -$5.27M | -$7.92M | -$9.88M | -$14.12M | — | +92.0% |
| End cash position | $1.54M | $1.96M | $7.12M | $8.32M | $18.21M | — | -21.3% |
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.00
Positioning, not flow
Max pain
0.50
-63.0% from spot
ATM implied vol
1650.0%
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
9
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
0.50
223 contracts
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Sep 2025 | -14.83 | -13.50 | +9.0% |
| Jun 2025 | -14.67 | -16.00 | -9.1% |
| Mar 2025 | -14.67 | -13.00 | +11.4% |
| Dec 2024 | -19.00 | -15.00 | +21.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders5.41%
Held by institutions21.37%
Institutions holding27
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.40
-3.64% from price
SMA 20
1.53
-11.59% from price
SMA 50
2.32
-41.73% from price
SMA 100
3.04
-55.54% from price
SMA 200
7.47
-81.92% from price
EMA 12
1.44
-6.40% from price
EMA 26
1.70
-20.78% from price
EMA 50
2.21
-39.00% from price
RSI (14)
39.3
Neutral
MACD (12,26,9)
-0.26
Hist 0.03
ATR (14)
0.38
28.38% of price
Realised vol 30D
294.2%
Annualised
Bollinger upper
2.11
20, 2σ
Bollinger lower
0.94
20, 2σ
50 / 200 cross
Death
2.32 vs 7.47
Trend bias
Below 200
-81.92%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.53
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
294.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-98.2%
Peak to trough
Max drawdown 5Y
-99.9%
Peak to trough
ATR 14
0.38
28.38% of price
Beta (reported)
0.63
5Y monthly, from filing
Short interest
Shares short
0
Prior 105.43K
Change vs prior
-100.0%
Shorts covering
% of float
0.00%
Normal
% of shares out
0.00%
Against total outstanding
Days to cover
0.0
Liquid
Float
1.39M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 25 | JMP Securities | DOWNGRADE | Market Outperform | Market Perform |
| Mar 31, 25 | Citizens Capital Markets | MAINTAINED | Market Outperform | Market Outperform |
| Mar 31, 25 | HC Wainwright & Co. | MAINTAINED | Neutral | Neutral |
| Nov 13, 24 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Sep 16, 24 | JMP Securities | MAINTAINED | Market Outperform | Market Outperform |
| May 23, 24 | JMP Securities | MAINTAINED | Market Outperform | Market Outperform |
| May 15, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Mar 28, 24 | JMP Securities | MAINTAINED | Market Outperform | Market Outperform |
| Mar 27, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Dec 5, 23 | JMP Securities | MAINTAINED | Market Outperform | Market Outperform |
| Nov 8, 23 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Sep 25, 23 | JP Morgan | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split1:50
Split dateApr 6, 2026
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-29
Corporate Changes & Voting Matters
8-K · 2026-08-28
Periodic Financial Reports
10-Q · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-07-16
Proxy Statements
DEFA14A · 2026-06-03
Periodic Financial Reports
10-Q · 2026-05-15
Periodic Financial Reports
10-K/A · 2026-04-29
Corporate Changes & Voting Matters
8-K · 2026-04-02
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.